Perry L. Howard

1.3k total citations
35 papers, 1.1k citations indexed

About

Perry L. Howard is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Perry L. Howard has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Perry L. Howard's work include RNA Research and Splicing (6 papers), Muscle Physiology and Disorders (5 papers) and MicroRNA in disease regulation (4 papers). Perry L. Howard is often cited by papers focused on RNA Research and Splicing (6 papers), Muscle Physiology and Disorders (5 papers) and MicroRNA in disease regulation (4 papers). Perry L. Howard collaborates with scholars based in Canada, United States and United Kingdom. Perry L. Howard's co-authors include Peter N. Ray, Henry J. Klamut, Pamela Plant, Herman Yeger, Olivier Staub, Daniela Rotin, Nicholas H. Heintz, L. A. Rogers, Spencer C. Alford and Marie C. Chia and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Perry L. Howard

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perry L. Howard Canada 20 795 161 138 116 109 35 1.1k
Graciana Diez‐Roux Italy 11 775 1.0× 98 0.6× 62 0.4× 124 1.1× 159 1.5× 11 1.3k
Yoshimasa Inagaki Japan 17 702 0.9× 254 1.6× 96 0.7× 163 1.4× 55 0.5× 27 1.4k
J. Bradley Dickerson United States 6 742 0.9× 164 1.0× 95 0.7× 101 0.9× 360 3.3× 6 1.2k
Michael W. Olszowy United States 10 618 0.8× 171 1.1× 57 0.4× 102 0.9× 175 1.6× 13 1.6k
F H Chang Taiwan 9 700 0.9× 92 0.6× 125 0.9× 109 0.9× 162 1.5× 10 955
Robert Shiurba Japan 20 546 0.7× 167 1.0× 112 0.8× 165 1.4× 147 1.3× 42 1.2k
Éric Lacazette France 18 914 1.1× 175 1.1× 117 0.8× 82 0.7× 124 1.1× 34 1.3k
Susan M. Carroll United States 15 667 0.8× 111 0.7× 115 0.8× 67 0.6× 56 0.5× 19 1.2k
T. Fujiwara Japan 20 763 1.0× 212 1.3× 55 0.4× 49 0.4× 185 1.7× 36 1.1k
Chris Gordon United States 15 565 0.7× 100 0.6× 73 0.5× 53 0.5× 59 0.5× 32 979

Countries citing papers authored by Perry L. Howard

Since Specialization
Citations

This map shows the geographic impact of Perry L. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry L. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry L. Howard more than expected).

Fields of papers citing papers by Perry L. Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry L. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry L. Howard. The network helps show where Perry L. Howard may publish in the future.

Co-authorship network of co-authors of Perry L. Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Perry L. Howard. A scholar is included among the top collaborators of Perry L. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry L. Howard. Perry L. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamilton, Phineas T., Alex Miranda, Robert L. Chow, et al.. (2022). Cytoplasmic switch of ARS2 isoforms promotes nonsense-mediated mRNA decay and arsenic sensitivity. Nucleic Acids Research. 50(3). 1620–1638. 3 indexed citations
2.
Bromma, Kyle, Wonmo Sung, Perry L. Howard, et al.. (2019). Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy. British Journal of Radiology. 93(1106). 20190742–20190742. 26 indexed citations
3.
Howard, Perry L., et al.. (2018). Mapping the Pax6 3’ untranslated region microRNA regulatory landscape. BMC Genomics. 19(1). 820–820. 6 indexed citations
4.
Alford, Spencer C., et al.. (2018). Protecting Pax6 3′ UTR from MicroRNA-7 Partially Restores PAX6 in Islets from an Aniridia Mouse Model. Molecular Therapy — Nucleic Acids. 13. 144–153. 11 indexed citations
5.
Howard, Perry L., et al.. (2016). ImiRP: a computational approach to microRNA target site mutation. BMC Bioinformatics. 17(1). 190–190. 15 indexed citations
6.
Alford, Spencer C., et al.. (2014). Conditional protein splicing of α-sarcin in live cells. Molecular BioSystems. 10(4). 831–837. 7 indexed citations
7.
Nickerson, Philip E. B., Kara Ronellenfitch, Jamie D. Boyd, et al.. (2013). Live imaging and analysis of postnatal mouse retinal development. BMC Developmental Biology. 13(1). 24–24. 12 indexed citations
8.
Alford, Spencer C., Adam Watson, Nadia Aleyna Scott, et al.. (2010). Soluble ephrin a1 is necessary for the growth of HeLa and SK-BR3 cells. Cancer Cell International. 10(1). 41–41. 26 indexed citations
9.
Alford, Spencer C., Joel D. Pearson, Amanda Carette, Robert J. Ingham, & Perry L. Howard. (2009). alpha-Sarcin catalytic activity is not required for cytotoxicity. BMC Biochemistry. 10(1). 9–9. 21 indexed citations
10.
Chow, Robert L., et al.. (2009). Expression of the putative microRNA processing protein, Ars2, in the developing and adult mouse retina. Developmental Biology. 331(2). 511–511. 1 indexed citations
11.
Lau, K., et al.. (2009). Salt-resistant blood pressure and salt-sensitive renal autoregulation in chronic streptozotocin diabetes. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 296(6). R1761–R1770. 22 indexed citations
12.
Alford, Spencer C., et al.. (2007). Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers. Experimental Cell Research. 313(20). 4170–4179. 26 indexed citations
13.
Montáñez, Cecilia, Peter N. Ray, Perry L. Howard, et al.. (2000). Alternative splicing regulates the nuclear or cytoplasmic localization of dystrophin Dp71. FEBS Letters. 482(3). 209–214. 32 indexed citations
14.
Austin, Richard C., Glenn E. Morris, Perry L. Howard, Henry J. Klamut, & Peter N. Ray. (2000). Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain. Neuromuscular Disorders. 10(3). 187–193. 52 indexed citations
15.
Pillers, De‐Ann M., Richard G. Weleber, Daniel G. Green, et al.. (1999). Effects of Dystrophin Isoforms on Signal Transduction through Neural Retina: Genotype–Phenotype Analysis of Duchenne Muscular Dystrophy Mouse Mutants. Molecular Genetics and Metabolism. 66(2). 100–110. 52 indexed citations
16.
Howard, Perry L., et al.. (1999). Dystrophin isoforms Dp71 and Dp427 have distinct roles in myogenic cells. Muscle & Nerve. 22(1). 16–27. 32 indexed citations
17.
18.
Plant, Pamela, Herman Yeger, Olivier Staub, Perry L. Howard, & Daniela Rotin. (1997). The C2 Domain of the Ubiquitin Protein Ligase Nedd4 Mediates Ca2+-dependent Plasma Membrane Localization. Journal of Biological Chemistry. 272(51). 32329–32336. 166 indexed citations
19.
Howard, Perry L., et al.. (1992). Oncogenes and antioncogenes in human breast carcinoma.. PubMed. 27 Pt 1. 321–42. 9 indexed citations
20.
Heintz, Nicholas H., et al.. (1990). Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.. PubMed. 114(2). 160–3. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Graciana Diez‐Roux Breakdown of academic impact, for papers by Yoshimasa Inagaki Breakdown of academic impact, for papers by J. Bradley Dickerson Breakdown of academic impact, for papers by Michael W. Olszowy Breakdown of academic impact, for papers by F H Chang Breakdown of academic impact, for papers by Robert Shiurba Breakdown of academic impact, for papers by Éric Lacazette Breakdown of academic impact, for papers by Susan M. Carroll Breakdown of academic impact, for papers by T. Fujiwara Breakdown of academic impact, for papers by Chris Gordon
Rankless by CCL
2026